Biomerica appoints Gary Lu as CFO effective March 1, 2023

BIOMERICA INC

Gary Lu, 42, previously Controller/VP Finance at Happy Money (Sep 2019-Feb 2023).
Lu receives $260,000 base salary and option for 75,000 shares vesting 25% annually over 4 years.
Steve Sloan steps down as interim CFO but remains advisor through Q3 FY2023 10-Q filing.
Lu is a CPA with a BA in Economics/Accounting from UCLA; began career at Ernst & Young.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Gary Lu

Chief Financial Officer

BMRA · BIOMERICA INC

Effective: 2023-03-01
Filed: March 2, 2023, 6:59 PM ET

Effective March 1, 2023, the Board of Directors of Biomerica, Inc. (the “Company”) appointed Gary Lu as its Chief Financial Officer, principal financial officer and principal accounting officer.

Departed

Steve Sloan

interim Chief Financial Officer

BMRA · BIOMERICA INC

Effective: 2023-03-01
Successor: Gary Lu
Filed: March 2, 2023, 6:59 PM ET

In connection with Mr. Lu’s appointment as Chief Financial Officer, Steve Sloan, the Company’s former Chief Financial Officer and current interim Chief Financial Officer, stepped down as interim Chief Financial Officer, effective as of March 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Gary Lu was appointed as Chief Financial Officer at BIOMERICA INC.

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

Effective March 1, 2023, the Board of Directors of Biomerica, Inc. (the “Company”) appointed Gary Lu as its Chief Financial Officer, principal financial officer and principal accounting officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 1.0

Steve Sloan departed as interim Chief Financial Officer at BIOMERICA INC.

Action: stepped down
Role: interim Chief Financial Officer

Exact text from the filing

In connection with Mr. Lu’s appointment as Chief Financial Officer, Steve Sloan, the Company’s former Chief Financial Officer and current interim Chief Financial Officer, stepped down as interim Chief Financial Officer, effective as of March 1, 2023.

View on SEC.gov

BIOMERICA INC filing history →

Source: SEC EDGAR

accession 0001513162-23-000023

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.